Targeting EP2 Receptor With Multifaceted Mechanisms for High-Risk Neuroblastoma

Researchers reported that knockout of EP2 in neuroblastoma (NB) cells blocks the development of xenografts, and its conditional knockdown prevents established tumors from progressing.